11 results
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... Initiative (PAMI ... #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Initiative (PAMI ... #Management # ... Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Initiative (PAMI ... Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Initiative (PAMI ... Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Doses #Dosing ... #Table #PAMI
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... drugs. ... #pharmacology #dm2 ... #diabetes #medications ... #overview #management
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Initiative (PAMI ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Initiative (PAMI ... #Management # ... Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... This drug class ... #Pharmacology # ... Management #Diabetes ... #DM2 #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology #
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... Insulin dependent DM ... echo in the last year ... Diabetes regimen ... medical and surgical management